Publication date: September–October 2026 Source: Steroids, Volumes 233–234 Author(s): Tu M. Ho, Elyse K. Frydendall, Jiaying Zhou, Samuel D. Offei, Hadi D. Arman, Emily E. Scott, Francis K. Yoshimoto
Synthesis of steroids fused with a pyridine at C11-C12 to accommodate the active site ceiling of cytochrome P450 8B1. // Steroids. – URL: https://www.sciencedirect.com/science/article/pii/S0039128X26000589?dgcid=rss_sd_all
Synthesis of steroids fused with a pyridine at C11-C12 to accommodate the active site ceiling of cytochrome P450 8B1. Steroids. https://www.sciencedirect.com/science/article/pii/S0039128X26000589?dgcid=rss_sd_all
“Synthesis of steroids fused with a pyridine at C11-C12 to accommodate the active site ceiling of cytochrome P450 8B1.” Steroids.
@article{article119551,
title = {Synthesis of steroids fused with a pyridine at C11-C12 to accommodate the active site ceiling of cytochrome P450 8B1},
journal = {Steroids},
url = {https://www.sciencedirect.com/science/article/pii/S0039128X26000589?dgcid=rss_sd_all}
}
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01953-z IRAK4 inhibitor DW18134 ameliorates diffuse large B-cell lymphoma in combination with ibrutinib and overcomes acquired resistance to ibrutinib
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01958-8 Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00179-2 The NIH’s P. J. Brooks discusses the challenges and opportunities ahead for gene therapies and gene editing for diseases of no commercial interest.
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00181-8 Merck and Moderna’s intismeran autogene succeeded in a landmark melanoma trial, but the oncology community still has more questions than...